Mismatch repair in V region mutation and isotype switching

V区突变和同种型转换中的错配修复

基本信息

  • 批准号:
    7579404
  • 负责人:
  • 金额:
    $ 32.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Germinal center B cells undergo a high rate of somatic mutation and recombination of their immunoglobulin genes that is responsible for the affinity maturation and isotype switching that generates protective antibodies. These processes are initiated by activation induced cytidine deaminase which generates G:U mismatches that are processed by replication, base excision repair and mismatch repair to produce the mutations required for somatic hypermutation of antibody variable and switch regions. Mismatch repair is responsible for ~60% of the total mutations and most of the mutations in A:T bases that lead to production of more effective antibodies. While mismatch repair normally maintains the integrity and stability of the genome, at the Ig gene it mediates extensive mutation and recombination. Here we propose to examine how germinal center B cells use mismatch repair to recruit error prone repair to specific regions of the immunoglobulin genes while continuing to maintain genomic stability in the rest of genome and to examine role of mismatch repair in the B cell lymphomagenesis. We will do this by: 1) determining how MSH6 and the other mismatch repair proteins interact with PCNA to recruit error prone repair to the immunoglobulin variable and switch regions, but not to other genes in mutating and switching germinal center B cells; 2) comparing the interactions of the mismatch repair proteins with each other and with other proteins in mutating and switching B cells and with those interactions in other types of cells; and 3) examining the characteristics of the lymphomas that arise in MSH6 deficient and mutant mice in order to understand how MSH6 protects B cells from lymphomagenesis. PUBLIC HEALTH RELEVANCE: To protect us from pathogenic organisms, it is necessary for us to produce antibodies to every possible antigen and to rapidly change those antibodies as the pathogen changes. We do this by introducing many mutations into the genes that encode the antibody molecules as we respond to infection and this genetic instability is accomplished mostly through a process called mismatch repair. We will use mice that have genetic defects in mismatch repair to examine how the generation of antibody diversity is accomplished.
描述(由申请人提供):生发中心B细胞经历了高比率的体细胞突变和免疫球蛋白基因的重组,这是亲和力成熟和同型转换产生保护性抗体的原因。这些过程是由激活诱导的胞苷脱氨酶启动的,它产生G:U错配,通过复制、碱基切除修复和错配修复来产生抗体可变区和开关区的体细胞超突变所需的突变。错配修复是导致产生更有效抗体的A:T碱基突变总数的60%和大部分突变的原因。虽然错配修复通常维持基因组的完整性和稳定性,但在Ig基因,它介导了广泛的突变和重组。在这里,我们建议研究生发中心B细胞如何利用错配修复来招募容易出错的修复到免疫球蛋白基因的特定区域,同时继续维持基因组其余部分的基因组稳定性,并研究错配修复在B细胞淋巴瘤发生中的作用。我们将通过:1)确定MSH6和其他错配修复蛋白如何与增殖细胞核抗原相互作用,以招募容易出错的修复到免疫球蛋白可变和切换区,但不到生发中心B细胞的其他基因;2)比较错配修复蛋白彼此之间以及在突变和切换B细胞中与其他蛋白质的相互作用;以及3)检测在MSH6缺陷和突变的小鼠中出现的淋巴瘤的特征,以了解MSH6如何保护B细胞免受淋巴生成的影响。公共卫生相关性:为了保护我们免受病原体的侵害,我们有必要针对每一种可能的抗原产生抗体,并随着病原体的变化而迅速改变这些抗体。当我们对感染做出反应时,我们通过在编码抗体分子的基因中引入许多突变来做到这一点,而这种遗传不稳定性主要是通过一种称为错配修复的过程完成的。我们将使用在错配修复中有遗传缺陷的小鼠来检查抗体多样性的产生是如何完成的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATTHEW D SCHARFF其他文献

MATTHEW D SCHARFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATTHEW D SCHARFF', 18)}}的其他基金

Hybridoma (Monoclonal Antibody) Core
杂交瘤(单克隆抗体)核心
  • 批准号:
    7706296
  • 财政年份:
    2008
  • 资助金额:
    $ 32.46万
  • 项目类别:
IMMUNO-ONCOLOGY
免疫肿瘤学
  • 批准号:
    7506791
  • 财政年份:
    2007
  • 资助金额:
    $ 32.46万
  • 项目类别:
PROGRAM LEADERS
项目负责人
  • 批准号:
    7506775
  • 财政年份:
    2007
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch repair in V region mutation and isotype switching
V区突变和同种型转换中的错配修复
  • 批准号:
    8403693
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch repair in V region mutation and isotype switching
V区突变和同种型转换中的错配修复
  • 批准号:
    7758277
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch Repair in V region mutation and isotype switch
V区突变和同种型转换中的错配修复
  • 批准号:
    7076248
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch repair in V region mutation and isotype switching
V区突变和同种型转换中的错配修复
  • 批准号:
    9132482
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch repair in V region mutation and isotype switching
V区突变和同种型转换中的错配修复
  • 批准号:
    9109534
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch Repair in V region mutation and isotype switch
V区突变和同种型转换的错配修复
  • 批准号:
    6925507
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
Mismatch repair in V region mutation and isotype switching
V区突变和同种型转换中的错配修复
  • 批准号:
    8900937
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 32.46万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 32.46万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 32.46万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 32.46万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了